Photo Albums

The Vaccine Formulation Institute (VFI) and Seppic are pleased to announce that they are expanding their partnership to support the large-scale manufacturing and availability of a [...]

Zabala, B.A., et al. Induction of Sustained Immunity Following Vaccination with Live Attenuated Trypanosoma cruzi Parasites Combined with Saponin-Based Adjuvants. Biology (Basel), 2025 Sep 20, [...]

Cao, H., et al. A Comparative Study on Immune Protection Efficacy: An HSV-1 Trivalent Antigen Subunit Vaccine Formulated with a Cellular Immunity-Inducing Adjuvant Versus an mRNA Vaccine. [...]

Bissa, M., et al. HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques. Nat Commun, 2025 Sep 29, 16(1):8571. PMID: 41022728 This paper explores [...]

The Desert King innovation strategy focuses on research, sustainability, and biotechnology to strengthen the company’s impact worldwide. The backing of this instrument allowed Desert King’s [...]

A 100% biodegradable suppressant developed from the quillay tree is transforming electrowinning and electrorefining plants around the world, protecting people, safeguarding assets, and offering a [...]

Responsible Management:  Desert King leads quillay traceability and sustainable management with FSC® certification  The company is the only one in the quillay industry to hold FSC® Chain of [...]

Recbio Technology is conducting a Phase 3 clinical trial for its novel adjuvanted recombinant shingles vaccine REC610 in China. Jiangsu Recbio Technology Co., Ltd. is pleased to announce that the [...]

Destexhe, E. A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines. NPJ Vaccines, 2025 Aug 13, 10(1):192. PMID: 40804241 This study supports a [...]

Valadares, D.G., et al. LeishTec vaccination disrupts vertical transmission of Leishmania infantum. PLoS Negl Trop Dis, 2025 Jul 30. PMID: 40737310 LeishTec is a recombinant vaccine adjuvanted [...]